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Chronic lung disease of prematurity
Bronchial hyperresponsiveness
Methacholine
Histaminea b s t r a c t
Being born preterm often adversely affects later lung function. Airway obstruction and bronchial hyper-
responsiveness (BHR) are common findings. Respiratory symptoms in asthma and in lung disease after
preterm birth might appear similar, but clinical experience and studies indicate that symptoms sec-
ondary to preterm birth reflect a separate disease entity.
BHR is a defining feature of asthma, but can also be found in other lung disorders and in subjects with-
out respiratory symptoms. We review different methods to assess BHR, and findings reported from stud-
ies that have investigated BHR after preterm birth. The area appeared understudied with relatively few
and heterogeneous articles identified, and lack of a pervasive understanding. BHR seemed related to
low gestational age at delivery and a neonatal history of bronchopulmonary dysplasia. No studies
reported associations between BHR after preterm birth and the markers of eosinophilic inflammatory air-
way responses typically found in asthma. This should be borne in mind when treating preterm born indi-
viduals with BHR and airway symptoms.
 2017 The Authors. Published by Elsevier Ltd. This is anopenaccess article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction course of an individual. Respiratory complications are important,Preterm birth is a poorly understood, relatively common and
potentially serious early life event that can affect the entire lifeas early birth implies that gas exchange must take place in foetal
and thus developmentally immature lungs. Symptoms often begin
shortly after birth and manifest as grunting, tachypnea, chest wall
retractions and increasing respiratory difficulty that can develop
into respiratory failure. Unless appropriately treated, infant respi-
ratory distress syndrome (IRDS) carries a high risk of death.
Despite vast medical and technological advances, IRDS remains
challenging also in contemporary neonatal intensive care units
(NICUs). Prolonged periods of oxygen supplementation, ventilatory
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required. Although necessary to preserve life, these interventions
can paradoxically lead to life-long pulmonary injuries. Thus, in a
large proportion of survivors, extrauterine development of imma-
ture foetal lungs combined with injuries from life-saving neonatal
interventions can lead to the development of chronic lung disease
of prematurity (CLD), particularly in infants born ‘extremely
preterm’ (EP); i.e. before 28 weeks’ gestational age (GA) [1]. CLD,
often also called bronchopulmonary dysplasia (BPD), is commonly
defined by requirement for supplemental oxygen treatment for
more than 28 days of age, and further classified at 36 weeks GA
into mild, moderate or severe BPD [2].
Most long-term follow-up studies after EP-birth and BPD report
abnormal lung function, with variable degrees of airway obstruc-
tion, bronchial hyperresponsiveness (BHR), pulmonary hyperinfla-
tion and impaired gas diffusing capacity. Abnormalities tend to
increase with increasing immaturity and increasing severity of
BPD [1], and in recent studies, also with intrauterine growth
restriction [3,4], underlining potential influences of antenatal fac-
tors [5]. Autopsy studies of infants dying from BPD reveal increased
airway wall dimensions with smooth muscle hypertrophy and
abnormal elastin and collagen distribution, compatible with the
functional findings from follow-up studies [6,7]. Access to autopsy
studies and pathological specimens after infancy is scarce, and the
links between lung function, pulmonary structure and pathophys-
iology are unclear. For example, we do not know if lung disease
after preterm birth represents a consequence of previous structural
injuries, or a current active (inflammatory) airway disorder with
bronchospasm playing an important role. This lack of understand-
ing of the underlying mechanisms prevents rational and effective
therapy. Fundamental in this context, is a better understanding
of the phenomenon of bronchial hyper-responsiveness (BHR),
reported from several follow-up studies of preterm born individu-
als. The purpose of this review is to give an overview of current
knowledge pertaining to BHR in this vulnerable group of individu-
als (see Fig. 1).Fig. 1. Illustrating methacholine response in extremely preterm born subjects with
and without BPD. Previously published: Halvorsen, T., et al. (2005). Characteristics
of asthma and airway hyper-responsiveness after premature birth. Pediatr Allergy
Immunol 16(6): 487–494.Bronchial hyper-responsiveness
Overview
BHR refers to excessive airway narrowing in response to a vari-
ety of inhaled stimuli. BHR is a common feature of asthma; how-
ever, with significant overlap with the responsiveness that can be
found in non-asthmatic subjects. Thus, BHR is observed in almost
all patients with asthma, but also in a significant number of
individuals without respiratory complaints. It is customary to
divide the stimuli applied to assess BHR into two categories: direct
and indirect. Direct stimuli are pharmacological agents that act
directly on specific receptors on the bronchial smooth muscle, with
histamine and methacholine most commonly used. Indirect stimuli
act via mediator release from inflammatory cells in the airway
mucosa, and include exercise and eucapnic hyperventilation,
hyperosmolar aerosols such as saline or mannitol, and the pharma-
cologic agent adenosine monophosphate. Data indicate that BHR in
asthma can be split into a relatively persistent component and a
superimposed and more episodic component; best assessed
respectively by direct and indirect stimuli [8]. Direct stimuli are
seen as more sensitive and less specific than indirect challenges
in relation to asthma, whereas indirect BHR is more responsive
to treatment with inhaled corticosteroids and probably also more
closely linked to airway inflammation [9].
BHR is reported from most [10–22] but not all [23–26] follow-
up studies after preterm birth. Links between BHR and markers of
eosinophil airway inflammation have been difficult to establish in
ex-preterms [3,14]. However, recent data suggest presence of a
neutrophilic airway inflammation in BPD, possibly reflecting
mechanisms resembling those underlying chronic obstructive
pulmonary disease (COPD) [27].Mechanisms underlying increased BHR in preterm born survivors
BHR after preterm birth is poorly understood, and there is much
debate as to what extent it is a structural disorder or reflects an
active disease with on-going inflammation.
The ‘structural disease scenario’ can be seen as interstitial con-
sequences of the acute phases of IRDS and BPD. Limitation of max-
imal expiratory airflow depends on airway resistance, which must
reflect the cross-sectional dimension of medium sized bronchi,
which depends on the internal elastic recoil of the lung, which
again depends on adequate deposition of fibrous and elastic fibers
in the pulmonary interstitium [28]. As evidence of airway obstruc-
tion is reported from virtually all studies of ex-preterm individuals,
interactions between these factors must be negatively influenced
by preterm birth. In fact, altered elastic and fibrous networks are
described in lungs after exposure to oxygen supplementation and
positive pressure ventilation [29]. Regarding BHR, the capacity of
airway smooth muscle to shorten (and thereby reduce the size of
the airway lumen) in response to a maximal cholinergic stimulus
is attenuated by the elastic load (counter-pressure) that the lung
parenchyma can impose on the airway smooth muscle when it
contracts [30]. Loss of elastic recoil may thus lead to increased
responsiveness to methacholine. This line of thinking supports
the notion that BHR after premature birth is not an expression of
airway mucosal inflammation, but of pulmonary parenchymal
structural sequelae, and possibly related to distorted elastic and/
or fibrous architecture of the interstitium.
Support for the ‘active disease scenario’ would require data that
link BHR in ex-preterms to markers of airway inflammation. To
date, only a few studies have investigated airway inflammation
in the context of airway obstruction or BHR, and none have
reported the eosinophilic pattern typical for childhood asthma.
36 H.H. Clemm et al. / Paediatric Respiratory Reviews 26 (2018) 34–40As regards other types of inflammatory mechanisms, evidence of
oxidative stress in the airways assessed from analyses of exhaled
breath condensate led the authors to hypothesize that pro-
inflammatory activity might be involved [31,32]. These findings
need to be replicated by other research groups, but most agree that
the airway disease that follows preterm birth should be seen as a
distinct process to childhood asthma [33]. More research is clearly
needed in this area. The question to what extent this respiratory
disorder is due to stabilized early airway injuries and/or disrupted
lung growth and development, or reflects an active ongoing
disease, is currently unclear.Agents used to evaluate direct BHR
Direct stimuli act directly on receptors located on the airway
smooth muscle and may thereby induce airflow obstruction
depending on the dose administered and the characteristics of
the airways. Direct stimuli include methacholine and other mus-
carinic analogues, histamine, leukotrienes and prostaglandins.
Methacholine is the most commonly used test substance. It acts
directly on the muscarinic acetylcholine receptor, subtype M3
(mAChRsM3), located on the smooth airway muscle where it pro-
motes contraction and thereby airway obstruction [34]. Metha-
choline BHR is a sensitive marker of asthma but not very specific
[9,35]. Histamine works like methacholine through the cholinergic
pathway; however, additionally also through irritant receptors like
histamine H1 and H2 receptors and by activating sensory nerve
fibers in the airways. The mechanisms involved in bronchial
responsiveness to histamine is less well characterized and the
relative contribution from direct versus indirect effects is also
not clearly defined [36,37].
Direct airway responsiveness reflects airway smooth muscle
function, caliber and structure more than it reflects airway inflam-
mation, contrasting indirect stimuli that reflect airway inflamma-
tion and not so much airway muscle function.Outcome measures used to quantitate direct BHR
The outcome measure most commonly used to measure the air-
way response to direct BHR agents is the induced change in forced
expiratory volume in 1 s (FEV1). Most protocols define a positive
response as a drop of 20% in FEV1 compared to the baseline value,
although some use a decrease of 10% as cut-off. The provocation
dose [PD] or provocation concentration [PC] needed to induce this
reduction in FEV1 is often referred to as PD20 or PC20. Other out-
come parameters that have been used in children include changes
in oxygen saturation by 5%, induction of wheezing, or changes of
lung function parameters other than FEV1.Table 1
Comparison of direct and indirect tests for bronchial hyper-responsiveness.
Direct
Methacholine Histamine Exercise





Sensitivity for asthma High
Specificity for asthma Low
Mainly measures Muscle function/Airway Calibre
Dosage needed to induce BHR Low
* TLC = Total Lung Capacity.Methods used to test indirect BHR
These methods work through induction of bronchoconstriction
by activating one or more inflammatory pathways in the bronchial
mucosa, and involve release of mediators from inflammatory cells,
and/or of neuropeptides from sensory nerves. Indirect stimuli that
cause inflammatory cell mediator release include exercise [38] and
eucapnic voluntary hyperventilation [39,40], non-isotonic aerosols
[41], adenosine monophosphate (AMP) [42,43] and mannitol [44].
The airway response to indirect stimuli correlates better than
methacholine with eosinophilic airway inflammation [42,45,46].
Atopic individuals are more likely to have BHR to AMP than non-
atopic individuals [47], and a mannitol challenge is often negative
in asymptomatic individuals with BHR to methacholine [48].
Indirect BHR improves more than direct BHR after institution of
anti-inflammatory treatment [45] (Table 1).
Exercise
Exercise is the most commonly used method to test indirect
BHR. Exercise-induced bronchoconstriction (EIB) describes the
acute bronchial narrowing that occurs as a result of exercise. EIB
commonly occurs in asthma, but is also reported in individuals
without an established asthma diagnosis [49]. The symptoms of
EIB are variable and nonspecific; presence or absences of specific
respiratory symptoms have very poor predictive value for objec-
tively confirmed EIB [50]. Several studies indicate that subjects
who are predisposed to EIB have increased levels of exhaled nitric
oxide, leukotrienes, mast cell mediators and epithelial cell release
into the airway lumen [51–53]. Although the events that trigger
this syndrome are not fully understood, it is clear that inflamma-
tory mediators are released into the airways from eosinophils
and mast cells [49]. Populations at risk, such as children and
subjects with pre-existing cardiovascular disease, diabetes or lung
disease are also more sensitive to environmental exposures that
have been proposed to contribute to EIB [49]. The underlying
mechanisms of EIB are not fully understood. We know that inhaled
corticosteroids (ICS) are effective in EIB; however, corticosteroids
do not seem to be as protective in subjects who have EIB but no
established diagnosis of asthma [49].
Adenosine monophosphate (AMP)
AMP is a potent bronchoconstrictor in asthmatic patients, caus-
ing non-osmotic mast cell mediator release, primarily of histamine.
AMP may have additional actions on neural pathways as the air-
way response to AMP is partially attenuated by atropine and ipra-
tropium bromide [54,55]. AMP seems to be closely associated with
airway inflammation in patients with asthma, and BHR after AMPIndirect
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methacholine challenge [56–58]. BHR after AMP also seems to be
related to eosinophilic airway inflammation, and can be used as
a noninvasive marker of airway wall inflammation in asthma [59].
Eucapnic voluntary hyperventilation and isocapnic hyperventilation
(EVH/IHCA)
There are a number of surrogates for exercise in relation to
inducing bronchoconstriction, including eucapnic voluntary hyper-
ventilation (EVH) of dry air, inhalation of hyperosmolar aerosols of
4.5% saline or dry powder mannitol. However, none of these surro-
gate tests are completely sensitive or specific for EIB, although they
are all capable of identifying hyper-responsiveness. Isocapnic
hyperventilation with cold air (IHCA) is similar to EVH, aiming to
increase the sensitivity of BHR by inhaling cold and dry air.
Hypertonic saline
Inhalation of hypertonic saline (4,5%) was developed to investi-
gate the hypothesis that EIB was caused by a transient increase in
osmolarity of the airway surface liquid as a consequence of humid-
ifying large volumes of air during exercise [60]. The response
patterns seem to correlate well with exercise and EVH, and the
same mediators associated with exercise and EVH have been mea-
sured in response to hypertonic saline. However, the test is not
commonly used.
Mannitol
The mannitol challenge test was a further development of the
hypertonic saline challenge test [60]. Mannitol was selected
because it was generally regarded as a safe and feasible molecule
to be used in both adults and children. Mannitol had been shown
to stimulate release of histamine from mast cells, which was
enhanced in the presence of anti-IgE. Inhalation of dry powder
mannitol correlates well with other indirect challenges, and shares
many of the same characteristics of adenosine monophosphate
challenge. A positive test is consistent with the presence of inflam-
matory cells such as eosinophils and mast cells as well as their
mediators, and can therefore be used to confirm ongoing active
asthma.BHR in preterm-born children
Respiratory symptoms after preterm birth are in clinical set-
tings regrettably often seen as reflections of asthma; however,
the underlying pathophysiology suggests different causal mecha-
nisms. Asthma is characterized by a bronchial hyper-
responsiveness that is provoked by exposures to specific physical,
chemical or pharmacological stimuli [61]. As described, this BHR
can be quantified by determining the cumulative dose of various
provocative agents that induce a defined decline in lung function,
most commonly measured by FEV1 [62]. Importantly, BHR is a fea-
ture that is also observed in various chronic lung diseases other
than asthma, and occasionally also in asymptomatic subjects
[63–66]. The inconsistent extent of responsiveness that is observed
when subjects suffering from different respiratory diseases are
exposed to different provocative agents, indicate that various cau-
sal pathways must be involved. Thus, the causal mechanisms that
lead to BHR are complex, not fully understood and most probably
heterogeneous and vary between diseases.
BHR in asthma has been extensively studied, but the association
with parameters of airway inflammation is still a matter of debate[67] and the issue of ‘‘structural” versus inflammatory mechanisms
is still highly relevant [68,69]. For example, we know that BHR
increases with decreasing FEV1, cigarette smoking and atopy,
whereas a decrease is observed with increasing age [70,71]. BHR
in preterm born survivors has been much less studied, and no stud-
ies have found associations with markers of the inflammatory air-
way response that is so characteristic of asthma. In fact, the finding
that ex-preterms with BPD exhibit BHR to methacholine but not to
AMP support that bronchial hyper-responsiveness in preterm born
children may not be mediated by inflammatory factors [13]. A cou-
ple of studies have provided data that made the authors speculate
if BHR to methacholine in preterm born children could be related
to in utero modifications of the muscarinic M3 receptors due to
adverse exposures during fetal life [3,72]. They found extensive
BHR to methacholine in growth restricted extremely preterm born
11 year old children and in six year old children with faltering
intrauterine growth measured using repeated ultrasound assess-
ments. We know that several factors, such as nicotine and ethanol,
can cause epigenetic changes and interfere with the development
and function of M3 receptors in various organs of the offspring
[73,74]. In animal models, a protein-restricted diet [72] and even
maternal stress [75] have been linked to BHR in the offspring. Thus,
one may hypothesize that dysregulation of the M3 receptor due to
adverse antenatal influences in preterm born children may alter
the response to methacholine and lead to airway disease.
BHR in preterm born subjects have been studied using different
approaches in population samples that have varied as regards
important characteristics such as gestational age at birth, birth-
weight, age at testing and the treatment era into which the partic-
ipants were born. Moreover, not all studies have included control
subjects and the results are diverse. Thus, the results are challeng-
ing to summarize. We describe here a sample of the most relevant
studies, classified according to the provocation agent they used.Methacholine
Direct provocation with methacholine is the most commonly
used agent, and was used in 11 of the 20 studies we selected. Six
studies reported significant increases in BHR in subjects born pre-
term with BPD/CLD [11–16], and two studies reported the same
tendency, however not statistically significant [10,17]. Three stud-
ies did not find any significant BHR response in the preterm born
participants; however, the gestational age at birth of those
included were generally above 34 weeks [23–25]. Significantly
increased BHR in preterm born individuals without BPD was
reported only in studies of subjects who were born extremely pre-
term. The data is heterogeneous and the diversity seemed related
to characteristics of the study populations, most evidently gesta-
tional age at birth and the presence or absence of BPD. Overall,
the studies suggest that there is a higher risk of BHR in the more
immature preterm born survivors and in those who had prolonged
neonatal requirements for oxygen, and thus qualified for a neona-
tal diagnosis of BPD.Exercise induced bronchoconstriction (EIB)
Even if exercise is the most commonly used indirect BHR provo-
cation, there are only a few studies reporting on EIB in preterm
born subjects. Of the three studies that we identified [20–22],
one used treadmill running and two used cycle ergometer, and
all concluded that preterm born participants had a higher preva-
lence of EIB than the control group. In one study, the EIB responded
to salbutamol [21]. All of these studies included preterm born sub-
jects with a GA < 32 weeks or birthweight under 1500 g.
Fig. 2. Theoretical model illustrating the overlapping BHR response to methacholine in healthy and diseased. A responder is defined by a drop in FEV1 of 20% or more to a
given cumulative dose of methacholine. The bronchial responsiveness to methacholine demonstrated in preterm born individuals seems to overlap with that observed in
asthmatic individuals.
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We identified one study that used isocapnic hyperventilation
with cold air (IHCA). The authors reported that 25% of their pre-
term born population had a reduction in FEV1 after IHCA exposure
[76]. However, this study did not include a term born control
group, and was performed in a context testing multiple preterm
births; i.e. twins, triplets and quadruplets with gestational age at
birth varying from 28 to 38 weeks. Given the 25% response rate,
the conclusion proposed by the authors was that the prematurity
and the intrauterine growth pattern caused by multiparity do not
seem to be associated with BHR after provocation with IHCA.Histamine
Histamine is classified as a direct provocation agent, and is the
second most used substance (after methacholine) to test in pre-
term born subjects. The studies using histamine are heteroge-
neous, and the results inconsistent and difficult to interpret
[26,77–79]; Two studies reported increased BHR in their preterm
group [18,78], and the authors related their findings to very low
birth weight or being born very preterm. One study from the
Netherlands [26] looked at preterm born children (age range from
3 to 10 years) with and without respiratory symptoms in the
neonatal period, and did not find any significant difference in
BHR [26]. Koumbourlis et al. [77] longitudinally followed 17 pre-
term born children with CLD and found a gradual improvement
in lung function into adolescence. At 15 years of age only 4 of 17
had BHR to histamine, and it appeared to be associated with small
airway obstruction. They speculated if BHR is an inborn trait lead-
ing to both neonatal BPD and later lung disease, or if it is a result of
neonatal airway injuries. Interpretation is, however, difficult as the
authors did not include a comparison term-born group. The study
by Bertrand et al. [79] compared preterm born subjects with and
without RDS; each paired with a sibling born at term. BHR was also
tested in their mothers. Expiratory flow was decreased in all the
ex-preterm children, and this was strongly correlated to prolonged
neonatal exposure to oxygen. BHR was elevated in all groups
including their mothers and their term-born siblings, and the
authors suggested that lung sequela in premature born childrenwithout a history of RDS is related to BHR alone and that there also
may be a relation between familial BHR and premature birth. This
familial association for BHR has been reported also by others [80];
however, the Silverman group found that BHR after histamine
where correlated to a history of asthma, but they were unable to
find evidence to support the hypothesis that BHR in mothers has
a causative role in the premature labor and subsequent BHR in
their prematurely born children [81].
AMP
Two studies using AMP to address BHR in preterm born children
reported no correlation with respiratory symptoms [12,13]. Kim
et al. [13] used both methacholine and AMP, and found BHR to
AMP only in those with symptoms of asthma. They also concluded
that children with a neonatal history of BPD do not have the
inflammatory airway response that is characteristic of asthma.
Two previous studies support this notion, and stated that BHR to
methacholine is present in both asthma and chronic lung diseases
[82], whereas BHR to AMP seems to be present only in asthma [83]
but not in CLD/BPD. This finding is consistent with a report from
2005 [14], also showing that BHR in preterm born subjects differed
from asthma and was best explained by neonatal events, particu-
larly prolonged requirements for oxygen treatment.Conclusion
BHR seems to be increased in preterm born children, most evi-
dently reported from studies that include the most immature par-
ticipants or children with a neonatal history of bronchopulmonary
dysplasia. Interesting differences seems to be present between BHR
in children with asthma and lung disease after preterm birth, with
no signs of eosinophilic inflammatory pathways reported for the
latter group. This suggests that different pathophysiological mech-
anisms are involved in these two conditions, supporting the view
that asthma therapy should not be uncritically applied in children
with respiratory symptoms following preterm birth. BHR is an
understudied characteristic in preterm born children, hampering
a more fundamental understanding of their lung disorder and also
complicating a research based approach to treatment.
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Directions for future research
 Investigate the causal factors that are involved in bronchial
hyper- responsiveness in preterm born individuals, and partic-
ularly if it represents an active ongoing disease or a structural
sequelae.
 Explore the life-long consequences of bronchial hyper-
responsiveness after being prematurely born.
 Investigate links between bronchial hyper-responsiveness and
clinical disease, and establish evidence based treatment
schemes.
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